Načítá se...
Clinical manufacturing of CAR T cells: foundation of a promising therapy
The treatment of cancer patients with autologous T cells expressing a chimeric antigen receptor (CAR) is one of the most promising adoptive cellular therapy approaches. Reproducible manufacturing of high-quality, clinical-grade CAR-T cell products is a prerequisite for the wide application of this t...
Uloženo v:
| Vydáno v: | Mol Ther Oncolytics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4909095/ https://ncbi.nlm.nih.gov/pubmed/27347557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2016.15 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|